| pubmed-article:3788500 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3788500 | lifeskim:mentions | umls-concept:C0019557 | lld:lifeskim |
| pubmed-article:3788500 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:3788500 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:3788500 | pubmed:dateCreated | 1987-1-12 | lld:pubmed |
| pubmed-article:3788500 | pubmed:abstractText | The effect of either heparin-dihydergot or heparin-acenocoumarin on the incidence of deep-vein thrombosis in the legs was studied in 181 women undergoing Ender nailing for intertrochanteric fracture of the femur. All the patients were screened with the 125-I-fibrinogen uptake test, confirmed by a bilateral ascending venogram. Deep-vein thrombosis developed in 40 per cent of the heparin-dihydergot group and in 61 per cent of the heparin-acenocoumarin group (p less than 0.015). | lld:pubmed |
| pubmed-article:3788500 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3788500 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3788500 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3788500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3788500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3788500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3788500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3788500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3788500 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3788500 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3788500 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:3788500 | pubmed:issn | 0001-6470 | lld:pubmed |
| pubmed-article:3788500 | pubmed:author | pubmed-author:KudernaHH | lld:pubmed |
| pubmed-article:3788500 | pubmed:author | pubmed-author:WelzelDD | lld:pubmed |
| pubmed-article:3788500 | pubmed:author | pubmed-author:PelinkaHH | lld:pubmed |
| pubmed-article:3788500 | pubmed:author | pubmed-author:SchlagGG | lld:pubmed |
| pubmed-article:3788500 | pubmed:author | pubmed-author:GaudernakTT | lld:pubmed |
| pubmed-article:3788500 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3788500 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:3788500 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3788500 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3788500 | pubmed:pagination | 340-3 | lld:pubmed |
| pubmed-article:3788500 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:meshHeading | pubmed-meshheading:3788500-... | lld:pubmed |
| pubmed-article:3788500 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:3788500 | pubmed:articleTitle | Thromboembolic prophylaxis in hip fracture. | lld:pubmed |
| pubmed-article:3788500 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3788500 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:3788500 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:3788500 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
